KUSH PARMAR
CIK 1664281 · Co-CEO · last filed 2025-11-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$71.64M
Companies
10
Total Filings
53
Lifetime Open-Market Net
$7.55M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRDA | Director | 1,093,313 | $6.46 | $7.06M | $2.17M | 9 | 2025-11-18 |
| RLYB | Director | 2,378,969 | $15.92 | $37.87M | $1.26M | 11 | 2024-05-17 |
| Akouos, Inc. (AKUS) Delisted | Director | 0 | $13.29 | $0 | -$3.46M | 5 | 2022-12-02 |
| Q32 Bio Inc. (FIXX) Delisted | Director | 4,354,484 | $16.82 | $73.26M | -$37.36M | 13 | 2022-06-17 |
| VOR | Director | 1,766,634 | $14.36 | $25.37M | $4.94M | 3 | 2022-06-16 |
| 5:01 Acquisition Corp. (FVAM) Delisted | Co-CEO | 365,126 | $10.00 | $3.65M | $0 | 4 | 2020-12-01 |
| APRE | 10%+ Owner | 1,926,073 | $0.69 | $1.32M | $40.00M | 1 | 2019-10-09 |
| ARVN | Director | 1,775 | $7.58 | $13.5K | $0 | 3 | 2019-09-26 |
| scPharmaceuticals Inc. (SCPH) Delisted | Director | — | $5.67 | — | $0 | 1 | 2018-06-21 |
| BOLD | Director | — | $1.41 | — | $0 | 3 | 2018-06-08 |
Recent Filings · Page 3 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-05 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2021-11-18 | VOR | Sell (S) | −330,706 | -$5.06M | EDGAR |
| 2021-11-05 | TRDA | Mixed | +4,077,224 | $5.00M | EDGAR |
| 2021-11-01 | TRDA | Grant (A) | — | $0 | EDGAR |
| 2021-08-04 | RLYB | Mixed | +4,190,724 | $8.00M | EDGAR |
| 2021-06-25 | Akouos, Inc. (AKUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-22 | Q32 Bio Inc. (FIXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-09 | VOR | Mixed | +6,692,429 | $10.00M | EDGAR |
| 2020-12-31 | Akouos, Inc. (AKUS) Delisted | Sell (S) | −470,000 | -$8.46M | EDGAR |
| 2020-12-28 | Q32 Bio Inc. (FIXX) Delisted | Sell (S) | −500,000 | -$6.41M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.